The neural substrates of memory systems impairment in Alzheimer's disease. A PET study of resting brain glucose utilization.
about
Contributions of neuropsychology and neuroimaging to understanding clinical subtypes of mild cognitive impairmentRelations between hypometabolism in the posterior association neocortex and hippocampal atrophy in Alzheimer's disease: a PET/MRI correlative studyNeocortical and hippocampal glucose hypometabolism following neurotoxic lesions of the entorhinal and perirhinal cortices in the non-human primate as shown by PET. Implications for Alzheimer's disease.Revealing modular architecture of human brain structural networks by using cortical thickness from MRI.Heteromodal conceptual processing in the angular gyrusComparative semantic profiles in semantic dementia and Alzheimer's disease.Magnetic resonance and PET studies in the early diagnosis of Alzheimer's disease.Use of functional magnetic resonance imaging in the early identification of Alzheimer's disease.The role of neuroimaging in mild cognitive impairment.Altered neuronal gene expression in brain regions differentially affected by Alzheimer's disease: a reference data set.Age-related cognitive decline, mild cognitive impairment or preclinical Alzheimer's disease?Alzheimer's disease is associated with reduced expression of energy metabolism genes in posterior cingulate neurons.[Neuroimaging in Alzheimer's disease: a synthesis and a contribution to the understanding of physiopathological mechanisms].Intrinsic interhemispheric hippocampal functional connectivity predicts individual differences in memory performance ability.Relationships between hippocampal atrophy, white matter disruption, and gray matter hypometabolism in Alzheimer's disease.Longitudinal brain metabolic changes from amnestic mild cognitive impairment to Alzheimer's disease.Neural correlates of cognitive impairment in posterior cortical atrophy.The diagnosis and evaluation of dementia and mild cognitive impairment with emphasis on SPECT perfusion neuroimaging.Development and evaluation of thymoquinone-encapsulated chitosan nanoparticles for nose-to-brain targeting: a pharmacoscintigraphic study.Dissociating memory networks in early Alzheimer's disease and frontotemporal lobar degeneration - a combined study of hypometabolism and atrophy.Functional genomics of brain aging and Alzheimer's disease: focus on selective neuronal vulnerability.Sex differences in grey matter atrophy patterns among AD and aMCI patients: results from ADNIA gene-brain-cognition pathway for the effect of an Alzheimer׳s risk gene on working memory in young adults.Vascular β-amyloid and early astrocyte alterations impair cerebrovascular function and cerebral metabolism in transgenic arcAβ mice.Relation between medial temporal atrophy and functional brain activity during memory processing in Alzheimer's disease: a combined MRI and SPECT studyThe topography of metabolic deficits in posterior cortical atrophy (the visual variant of Alzheimer's disease) with FDG-PET.Occipital hypoperfusion in Parkinson's disease without dementia: correlation to impaired cortical visual processingThe cerebral correlates of different types of perseveration in the Wisconsin Card Sorting Test.Early-Phase 11C-PiB PET in Amyloid Angiopathy-Related Symptomatic Cerebral Hemorrhage: Potential Diagnostic Value?Memory failure has different mechanisms in subcortical stroke and Alzheimer's diseaseWhen Higher Activations Reflect Lower Deactivations: A PET Study in Alzheimer's Disease during Encoding and Retrieval in Episodic Memory.Natural products and derivatives affecting neurotransmission relevant to Alzheimer's and Parkinson's disease.Stigmatization in Alzheimer's disease research on African American elders.Analysis of grey matter in thalamus and basal ganglia based on EEG α3/α2 frequency ratio reveals specific changes in subjects with mild cognitive impairment.Relationship between baseline brain metabolism measured using [¹⁸F]FDG PET and memory and executive function in prodromal and early Alzheimer's disease.Regional cerebral blood flow reductions, heart failure and Alzheimer's disease.Coevolution of brain structures in amnestic mild cognitive impairment.CREB regulates the expression of neuronal glucose transporter 3: a possible mechanism related to impaired brain glucose uptake in Alzheimer's diseaseMultiple systems of category learning.Differential patterns of hypoperfusion in subtypes of mild cognitive impairment.
P2860
Q24629087-6C478B53-EB30-4F81-AA86-FEECC8891203Q28346298-23598C14-C36F-4EAE-9482-4610CACCCDDDQ29030074-D95AE52E-93A0-4D06-BBAA-60C14EEDD188Q30489827-264F8557-A349-4B9F-8B98-14FF80DE9E05Q30537409-00670C73-9EF1-43F5-84FB-B1B8E67A65BCQ30541793-3EEA7A56-02FB-46ED-BBEE-CCED1519FA84Q30988163-11D57CE9-5FB9-459A-9986-142706C716B7Q31111440-1FF41503-A320-4224-9F6C-425FA5B1B41AQ31136940-C7F62A3C-D000-4F3E-A8A1-638359BD06A4Q31146509-5A970400-6700-4E96-BED4-60173C2BF95FQ31566966-E96A1C84-8205-4AFA-9B96-A26BAC6D2A8EQ33323272-08BA0E5B-02C9-4CBC-A17F-0F9880CBF182Q33720033-686E5D13-2DBB-4167-B4D2-07C8CE3F36F4Q33861814-E3D23471-7BE4-4C28-95BA-6BF175618C79Q33988394-7FA6102F-C882-4BA9-956A-D8651C1A4614Q34116029-8D5E3275-1B38-44D9-B55E-930641FFC512Q34177023-6F160A82-901C-4779-AD92-C6CCEF809FB4Q34296479-94A67C9E-C825-45EC-AE7C-229FA50E8939Q34488285-E995798E-EFCB-4F29-8550-29C39B2D89B7Q34606321-356C7E29-7A4E-424B-B4D3-935409A2BEC5Q34807482-8B3F5CC7-AFE8-44EC-8BC9-C564F2869DDCQ34901300-58CFAD67-AB1A-42AE-8CA3-3573157ED411Q35111848-02D4AA23-1EA6-4939-AA50-9991F301CBDBQ35200750-A830FB21-7A0F-4728-8790-7DFFF46AE561Q35469864-18E8894A-38D8-4F04-9CD3-7DDAE36C4C7CQ35471099-8E600789-7125-44BD-B557-EC4316C83D74Q35473005-EDA7F701-F1FA-485C-AA86-1EAEA6D27A88Q35485920-79B50D3F-760E-4C6D-8B32-2941CC6DEA0AQ35800210-B794AF69-F07B-4697-B69D-AD5AE46DD46EQ35855087-AE8CDC93-11C3-4045-A5E9-00ED27D50DDEQ35924590-C5A909D4-0D88-48D3-B5E1-73CE7468C9CDQ36163354-C3D67DFB-D411-438D-AF2A-DCE16EBB9505Q36311710-BEB3E9D3-67EE-4063-BD06-55F9FDECEB17Q36466486-75B739DE-4E0C-4749-84DF-B69E87AA5429Q36494819-E84F248B-A0E3-4260-B1AC-DFAEEB433212Q36582762-27B11A89-5D6C-4E8A-8117-F29312666888Q36672901-9B9E5742-485B-4BF6-838E-FCE611688C19Q36684722-F0AAF91C-CBB2-4283-B1B8-CD90EB136EB6Q36955340-EB670808-CF84-4AC1-AEF4-BAA29D0E662DQ36961555-AAE20347-BF82-4DF3-9DA7-B053FF8C0AE8
P2860
The neural substrates of memory systems impairment in Alzheimer's disease. A PET study of resting brain glucose utilization.
description
1998 nî lūn-bûn
@nan
1998年の論文
@ja
1998年論文
@yue
1998年論文
@zh-hant
1998年論文
@zh-hk
1998年論文
@zh-mo
1998年論文
@zh-tw
1998年论文
@wuu
1998年论文
@zh
1998年论文
@zh-cn
name
The neural substrates of memor ...... ing brain glucose utilization.
@en
type
label
The neural substrates of memor ...... ing brain glucose utilization.
@en
prefLabel
The neural substrates of memor ...... ing brain glucose utilization.
@en
P2093
P50
P356
P1433
P1476
The neural substrates of memor ...... ting brain glucose utilization
@en
P2093
B Lechevalier
M C Petit-Taboué
V de la Sayette
P304
P356
10.1093/BRAIN/121.4.611
P407
P478
121 ( Pt 4)
P577
1998-04-01T00:00:00Z